Starling Oncology (STLNW) EPS (Diluted) Growth (1y) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.22 Bn | 1.16 Bn | 45.97% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | -15.80% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | -0.46% |
| 4 | Concentra Group Holdings Parent | 4.26 Bn | 4.10 Bn | 192.10 Mn | 46.13% |
| 5 | Privia Health | 2.57 Bn | 2.15 Bn | - | 192.37% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | 6.62% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 78.89% |
| 8 | Surgery Partners | 1.84 Bn | 1.63 Bn | 622.10 Mn | -34.80% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.15 Bn | 41.94 Mn | -15.22% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 46.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.72% |
| Mar 31, 2026 | 90.13% |
| Dec 31, 2025 | 51.78% |
| Sep 30, 2025 | 19.31% |
| Jun 30, 2025 | 11.50% |
| Mar 31, 2025 | 22.18% |
| Dec 31, 2024 | 43.27% |
| Sep 30, 2024 | 26.15% |
| Jun 30, 2024 | 25.59% |
| Mar 31, 2024 | 34.40% |
| Dec 31, 2023 | -86.22% |
| Sep 30, 2023 | -605.62% |
| Jun 30, 2023 | -205.17% |
| Mar 31, 2023 | -261.47% |
| Dec 31, 2022 | 8.96% |
| Sep 30, 2022 | -179.50% |
| Jun 30, 2022 | 19.42% |
| Mar 31, 2022 | 178.91% |
| Dec 31, 2021 | -221,678,621.56% |
| Sep 30, 2021 | 85.70% |